| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/07/2011 | CA2593644C Fluoro-carbon emulsion enhancement agent for high intensity focused ultrasound treatment and use thereof |
| 06/07/2011 | CA2531646C Dry powder for inhalation comprising a formoterol salt and ciclesonide |
| 06/07/2011 | CA2500313C Polymer composition and dosage forms comprising the same |
| 06/07/2011 | CA2490573C Improved transdermal delivery system |
| 06/07/2011 | CA2471144C Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| 06/07/2011 | CA2466580C Orodispersible tablets containing fexofenadine |
| 06/07/2011 | CA2456977C Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/07/2011 | CA2442698C Thermolabile liposome with controlled release temperature |
| 06/07/2011 | CA2405705C The treatment of respiratory diseases |
| 06/07/2011 | CA2388857C Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same |
| 06/07/2011 | CA2368391C Human papillomavirus vaccine with disassembled and reassembled virus-like particles |
| 06/07/2011 | CA2361837C Human papilloma virus vaccine formulations |
| 06/07/2011 | CA2361496C Ph independent extended release pharmaceutical formulation |
| 06/07/2011 | CA2322954C Implantable particles for tissue bulking and the treatment of gastroesophageal reflux disease, urinary incontinence, and skin wrinkles |
| 06/07/2011 | CA2298823C Stabilized composition comprising a benzimidazole type compound |
| 06/03/2011 | WO2011066493A1 Conformable barrier sheet, methods, and device |
| 06/03/2011 | WO2011066390A2 Nanoscale adjuvants and related pharmaceutical compositions and methods |
| 06/03/2011 | WO2011066291A2 Lyophilization methods, compositions, and kits |
| 06/03/2011 | WO2011066287A1 Compressible-coated pharmaceutical compositions and tablets and methods of manufacture |
| 06/03/2011 | WO2011066260A2 Formulations comprising aminosterols |
| 06/03/2011 | WO2011066195A1 Systems and methods for fluid sample processing |
| 06/03/2011 | WO2011066107A1 Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease |
| 06/03/2011 | WO2011065966A1 Live bacteria product |
| 06/03/2011 | WO2011065867A2 Liposomes containing oligopeptide fragments of myelin basic protein, a pharmaceutical composition and a method for treatment of multiple sclerosis |
| 06/03/2011 | WO2011065754A2 Device for vaporisation and inhalation, a composition for vaporisation and inhalation used therewith, and a method for vaporising the composition for vaporisation and inhalation |
| 06/03/2011 | WO2011065600A1 Use of inhalable powder formulation comprising growth hormone for preventing or treating nmda receptor hypofunction-related diseases |
| 06/03/2011 | WO2011065551A1 Film coating agent for solid preparation, and solid preparation using same |
| 06/03/2011 | WO2011065350A1 Hydroxyalkylcellulose microparticles |
| 06/03/2011 | WO2011065184A1 Analgesic agent for external use, analgesic sheet, fabric, clothes, wall material, thermotherapeutic instrument, brain activation sheet and small pillow for brain activation |
| 06/03/2011 | WO2011065056A1 Polymersome and process for producing same |
| 06/03/2011 | WO2011064769A1 Methods and pharmaceutical compositions for the treatment of hot flashes |
| 06/03/2011 | WO2011064753A1 Pharmaceutical compositions and therapeutic applications of a hydrocortisone derivative designated as deina |
| 06/03/2011 | WO2011064631A1 Surfactant-free, water-free, foamable compositions and breakable foams and their uses |
| 06/03/2011 | WO2011064558A2 Pharmaceutical composition |
| 06/03/2011 | WO2011064315A1 4-[2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine salts |
| 06/03/2011 | WO2011064296A1 Pharmaceutical compositions comprising sigma receptor ligands |
| 06/03/2011 | WO2011064111A1 Film-like pharmaceutical dosage forms |
| 06/03/2011 | WO2011063952A1 Formulations of bisphosphonates and vitamin d suitable for intermittent intramuscular and subcutaneous administration |
| 06/03/2011 | WO2011063915A1 Liquid pharmaceutical compositions |
| 06/03/2011 | WO2011063776A2 Soluble beta-glucan-api complexes for pharmaceutical use |
| 06/03/2011 | WO2011063775A2 Pectin complexes of sartans and pharmaceutical compositions based thereon |
| 06/03/2011 | WO2011063753A1 Traditional chinese medicine composition for treating oral ulcer and tumor, preparation method and use thereof |
| 06/03/2011 | WO2011063732A1 Paliperidone double-layered osmotic pump controlled release tablet and preparation method thereof |
| 06/03/2011 | WO2011063606A1 Ophthalmic gel of gatifloxacin and preparation method thereof |
| 06/03/2011 | WO2011063605A1 Compound / glucose preparation |
| 06/03/2011 | WO2011063604A1 Compound / sodium chloride preparation |
| 06/03/2011 | WO2011063553A1 Traditional chinese medicine for treating flu induced by flu virus including type a h1n1 virus |
| 06/03/2011 | WO2011043918A3 Method of forming prolonged-release injectable steroids |
| 06/03/2011 | WO2011028416A3 Oral medication for the treatment of hemorrhoids and method of use |
| 06/03/2011 | WO2011025158A3 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof |
| 06/03/2011 | WO2011024168A3 Sustained release delivery systems for the prevention and treatment of head and neck cancers |
| 06/03/2011 | WO2011017483A3 Sublingual and buccal film compositions |
| 06/03/2011 | WO2011017195A3 Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith |
| 06/03/2011 | WO2010141879A9 Peptides for transport of therapeutics and their carriers in mouse models and humans |
| 06/03/2011 | WO2010138193A3 Targeted synthetic nanocarriers with ph sensitive release of immunomodulatory agents |
| 06/03/2011 | WO2010138192A3 Nanocarriers possessing components with different rates of release |
| 06/03/2011 | WO2010123945A9 Silk fibroin hydrogels and uses thereof |
| 06/03/2011 | WO2010122258A3 Method for producing free powder particles of polyamide impregnated with at least one cosmetic or pharmaceutical agent, and free powder particles of polyamide having a content of at least 25 wt % of at least one cosmetic or pharmaceutical agent |
| 06/03/2011 | WO2010103544A4 A novel sustained release composition of compounds selected from the class of centrally acting muscle relaxants |
| 06/03/2011 | WO2010091197A3 Tablets for combination therapy |
| 06/03/2011 | WO2010085696A9 Sustained released delivery of one or more agents |
| 06/03/2011 | WO2010077925A3 Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate |
| 06/03/2011 | WO2010026467A3 Controlled release tablet of a highly water soluble active agent such as levetiracetam, or citicoline |
| 06/03/2011 | WO2010024702A3 Pharmaceutical composition for the treatment of periodontal diseases |
| 06/03/2011 | WO2010006612A3 Canker sore patch |
| 06/03/2011 | CA2782177A1 Compressible-coated pharmaceutical compositions and tablets and methods of manufacture |
| 06/03/2011 | CA2782163A1 Ondansetron orally disintegrating tablet compositions for prevention of nausea and vomiting |
| 06/03/2011 | CA2782056A1 Mucosal delivery of peptides |
| 06/03/2011 | CA2781826A1 Controlled release pharmaceutical compositions of galantamine |
| 06/03/2011 | CA2781744A1 4-[2-[[5-methyl-1-(2-naphtalenyl)-1h-pyrazol-3-yl]oxy]ethyl]morpholine salts |
| 06/03/2011 | CA2781726A1 Pharmaceutical compositions comprising sigma receptor ligands |
| 06/03/2011 | CA2781229A1 Use of an oleogel containing triterpene for healing wounds |
| 06/03/2011 | CA2781120A1 Lyophilization methods, compositions, and kits |
| 06/03/2011 | CA2780138A1 Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease |
| 06/03/2011 | CA2777015A1 Film coating agent for solid preparation, and solid preparation using same |
| 06/03/2011 | CA2776471A1 Surfactant-free, water-free, foamable compositions and breakable foams and their uses |
| 06/03/2011 | CA2776331A1 Liquid pharmaceutical compositions |
| 06/02/2011 | US20110130616 Magnetically Responsive Nanoparticle Therapeutic Constructs and Methods of Making and Using |
| 06/02/2011 | US20110130461 Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders |
| 06/02/2011 | US20110130330 Topical Drug Delivery Using Phosphatidylcholine |
| 06/02/2011 | US20110129941 Method of Producing Polymeric Particles With Selected Size, Shape, Morphology and Composition |
| 06/02/2011 | US20110129801 Compositions and methods to prevent and treat dry socket post-operatively after tooth extraction surgery |
| 06/02/2011 | US20110129541 Suspension delivery system for the sustained and controlled local release of pharmaceuticals |
| 06/02/2011 | US20110129540 Polymer of acrylic or methacrylic type comprising alpha-tocopherol grafts |
| 06/02/2011 | US20110129539 Oral pharmaceutical formulation in the form of an aqueous suspension of microcapsules for modified release of amoxicillin |
| 06/02/2011 | US20110129538 Process for preparing orally administered dabigatran formulations |
| 06/02/2011 | US20110129537 Functionalized metal-coated energy converting nanoparticles, methods for production thereof and methods for use |
| 06/02/2011 | US20110129536 Nanocomposite materials based on metallic nanoparticles stabilized with branched polysaccharides |
| 06/02/2011 | US20110129535 Transdermal testosterone device and delivery |
| 06/02/2011 | US20110129534 Reduction of dermal scarring |
| 06/02/2011 | US20110129533 Porous drug matrices and methods of manufacture thereof |
| 06/02/2011 | US20110129532 Method and means for treating viral disease, in particular hiv/aids |
| 06/02/2011 | US20110129531 Dermal Fillers Comprising Silk Fibroin Hydrogels and Uses Thereof |
| 06/02/2011 | US20110129530 Compressible-Coated Pharmaceutical Compositions and Tablets and Methods of Manufacture |
| 06/02/2011 | US20110129529 Probiotic products for pet applications |
| 06/02/2011 | US20110129528 Sustained-release chitosan capsules comprising chitosan and phytic acid |
| 06/02/2011 | US20110129527 Rab3b for the treatment and prevention of parkinson's disease |
| 06/02/2011 | US20110129526 Compositions and methods for treating vascular disease |
| 06/02/2011 | US20110129525 Mucosal membrane receptor and uses thereof |
| 06/02/2011 | US20110129524 Therapeutic agent for cancer, and method for treatment of cancer |